Incidence of infections in patients with giant cell arteritis: a cohort study

Madeleine Durand1, Sara L Thomas

  • 1Centre Hospitalier de l'Universtité de Montréal, Montreal, Quebec, Canada. madeleine.durand.chum@ssss.gouv.qc.ca

Arthritis Care & Research
|December 21, 2011
PubMed

Insights

Patients with giant cell arteritis (GCA) face a significantly higher risk of systemic infections, especially within six months of diagnosis. This highlights the need for safer GCA treatments.

Area of Science:

  • Rheumatology
  • Infectious Diseases
  • Epidemiology

Background:

  • Giant cell arteritis (GCA) is the most common form of vasculitis in adults.
  • The infectious risk associated with GCA and its treatments is not well-established.

Purpose of the Study:

  • To estimate the risk of systemic infections in patients diagnosed with GCA.
  • To analyze infection risk in relation to GCA treatment, particularly focusing on steroid-sparing options.

Main Methods:

  • A matched historical cohort study was conducted using The Health Improvement Research Network data.
  • 1,664 GCA patients were matched with 8,078 non-GCA patients based on age, sex, general practice, and cohort entry date.
  • Random-effects Poisson regression models assessed incidence rates and rate ratios for lower respiratory tract infections (LRTI), urinary tract infections (UTI), and sepsis.

Main Results:

  • GCA patients had a higher incidence of systemic infections (48%) compared to non-GCA patients (37%).
  • Adjusted rate ratios for LRTI, UTI, and serious infections were significantly elevated in GCA patients (1.48, 1.27, and 1.55, respectively).
  • Infection risk was highest within the first six months post-GCA diagnosis and in patients younger than 75 years.

Conclusions:

  • This study provides the first evidence of an increased systemic infection risk in GCA patients.
  • The heightened risk is particularly pronounced in the initial months after GCA diagnosis.
  • There is a critical need for novel GCA medications that enable steroid-sparing therapy to mitigate infection risk.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...